SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 193,179.55 |
| Enterprise Value ($M) | 211,318.55 |
| Book Value ($M) | 60,898.00 |
| Book Value / Share | 28.31 |
| Price / Book | 3.17 |
| NCAV ($M) | -20,612.00 |
| NCAV / Share | -9.58 |
| Price / NCAV | -9.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.24 |
| Return on Assets (ROA) | 0.18 |
| Return on Equity (ROE) | 0.38 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.07 |
| Current Ratio | 1.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 36,954.00 |
| Assets | 118,464.00 |
| Liabilities | 57,566.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | BlackRock Inc. | 5.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 146,503 | 1,440,473 | 10.17 | |
| 381,222 | 2,774,979 | 13.74 | |
| 152,710 | 1,368,181 | 11.16 | |
| 146,846 | 990,087 | 14.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MYOV – Myovant Sciences Ltd. | NUVB – Nuvation Bio Inc |
| NVO – Novo-Nordisk A/S | OGN – Organon & Co. |
| PBH – Prestige Brands Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io